212 related articles for article (PubMed ID: 6813498)
1. Comparative pharmacokinetics of parenteral and oral gold compounds.
Gottlieb NL
J Rheumatol Suppl; 1982; 8():99-109. PubMed ID: 6813498
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and distribution of gold compounds.
Gottlieb NL
J Rheumatol Suppl; 1979; 5():2-6. PubMed ID: 114646
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the kinetics of parenteral and oral gold.
Gottlieb NL
Scand J Rheumatol Suppl; 1983; 51():10-4. PubMed ID: 6426043
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetics of oral and injectable gold compounds.
Blocka KL; Paulus HE; Furst DE
Clin Pharmacokinet; 1986; 11(2):133-43. PubMed ID: 3082559
[TBL] [Abstract][Full Text] [Related]
5. Auranofin versus injectable gold. Comparison of pharmacokinetic properties.
Blocka K
Am J Med; 1983 Dec; 75(6A):114-22. PubMed ID: 6419592
[TBL] [Abstract][Full Text] [Related]
6. Gold excretion and retention during auranofin treatment: a preliminary report.
Gottlieb NL
J Rheumatol Suppl; 1979; 5():61-7. PubMed ID: 385875
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology of auranofin: overview and update.
Gottlieb NL
Scand J Rheumatol Suppl; 1986; 63():19-28. PubMed ID: 3110942
[TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacokinetics of triethylphosphine gold (auranofin) and gold sodium thiomalate (GST).
Furst DE; Dromgoole SH
Clin Rheumatol; 1984 Mar; 3 Suppl 1():17-24. PubMed ID: 6432409
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of auranofin in animals.
Intoccia AP; Flanagan TL; Walz DT; Gutzait L; Swagzdis JE; Flagiello J; Hwang BY; Dewey RH; Noguchi H
J Rheumatol Suppl; 1982; 8():90-8. PubMed ID: 6813497
[TBL] [Abstract][Full Text] [Related]
10. Distribution of gold in rat blood after intravenous administration of auranofin, gold sodium thiomalate and aurothioglucose to rats.
Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
J Rheumatol; 1983 Feb; 10(1):117-20. PubMed ID: 6405031
[TBL] [Abstract][Full Text] [Related]
11. Single dose pharmacokinetics of auranofin in rheumatoid arthritis.
Blocka K; Furst DE; Landaw E; Dromgoole S; Blomberg A; Paulus HE
J Rheumatol Suppl; 1982; 8():110-9. PubMed ID: 6813473
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of gold sodium thiomalate.
Waller ES; Massarella JW; Crout JE; Yakatan GJ
Res Commun Chem Pathol Pharmacol; 1982 Jul; 37(1):33-47. PubMed ID: 6812186
[TBL] [Abstract][Full Text] [Related]
13. [The pharmacology of gold compounds].
Juan H
Wien Klin Wochenschr Suppl; 1984; 156():7-13. PubMed ID: 6442062
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of gold following administration of auranofin (SK+FD-39162) and myochrysine to rats.
Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
J Rheumatol; 1980; 7(6):820-4. PubMed ID: 6782245
[TBL] [Abstract][Full Text] [Related]
15. Gold and thiol compounds in the treatment of rheumatoid arthritis: excretory fate and tissue distribution of thiomalate in relation to gold after administration of myocrisin (auro-thiomalate).
Jellum E; Munthe E; Guldal G; Aaseth J
Scand J Rheumatol Suppl; 1979; (28):28-36. PubMed ID: 109914
[TBL] [Abstract][Full Text] [Related]
16. The pharmacological profile of auranofin, an orally active gold compound.
Walz DT; DiMartino MJ; Griswold DE
Scand J Rheumatol Suppl; 1983; 51():16-25. PubMed ID: 6426049
[TBL] [Abstract][Full Text] [Related]
17. Review of auranofin, an oral chrysotherapeutic agent.
Delafuente JC; Osborn TG
Clin Pharm; 1984; 3(2):121-7. PubMed ID: 6426843
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action, pharmacology, clinical efficacy and side effects of auranofin. An orally administered organic gold compound for the treatment of rheumatoid arthritis.
Furst DE
Pharmacotherapy; 1983; 3(5):284-98. PubMed ID: 6417628
[TBL] [Abstract][Full Text] [Related]
19. Distribution of gold in blood following administration of auranofin (SK&F D-39162).
Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
J Rheumatol Suppl; 1979; 5():56-60. PubMed ID: 114638
[TBL] [Abstract][Full Text] [Related]
20. Biologic actions and pharmacokinetic studies of auranofin.
Walz DT; DiMartino MJ; Griswold DE; Intoccia AP; Flanagan TL
Am J Med; 1983 Dec; 75(6A):90-108. PubMed ID: 6318557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
